Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-396-2014

Drug recall · January 8, 2014

Niacin Extended Release Tablets recall

Why: Failed Tablet/Capsule Specifications: There is a potential for broken tablets.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98

Lots / codes

Lot#: 32900349B, Exp: 12/2014

Quantity
10,512 bottles
Company
Teva Pharmaceuticals USA, Horsham, PA
Distribution
Nationwide and Puerto Rico, American Samoa, Virgin Islands, and Canal Zone
Initiated
November 26, 2013 · Voluntary: Firm initiated
Classified
January 2, 2014
Reported
January 8, 2014
Ended
August 27, 2014
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Niacin

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.